Anticoagulant Linked With Lower Risk of Death Following Heart Attack Compared to Heparin
Tuesday, February 17, 2015 - 16:30
in Health & Medicine
Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months compared to patients who received low-molecular-weight heparin (LMWH), although both groups had similar rates of subsequent heart attack or stroke, according to a new study.